08:31 EDT Eli Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for up to $12.47 per share
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly, Incyte report results from BRAVE-AA-PEDS trial
- Eli Lilly reports findings from ADjoin extension trial of Ebglyss
- Eli Lilly’s New Phase 3 Study: A Potential Game-Changer for Alcohol Use Disorder
- Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer for Alcohol Use Disorder
- Trump Trade: Trump administration prepares new probe into pharma prices